JUVENTAS THERAPEUTICS
Juventas Therapeutics is a privately-held clinical-stage biotechnology company developing a pipeline of regenerative therapies to treat life–threatening diseases. Founded in 2007 with an exclusive license from the Cleveland Clinic, Juventas has transitioned its therapeutic platform from concept to initiation of mid-stage clinical trials. Investors include Triathlon Medical Venture Partners, Early Stage Partners, Fletcher Spaght Ventures, Reservoir Venture Partners, North Coast Angel Fund, X Gen Ltd., JumpStart Inc., and Blue Chip Venture Co. The company has received nondilutive grant support through the Ohio Third Frontier funded Cleveland Clinic Ohio BioValidation Fund, Global Cardiovascular Innovation Center and Center for Stem Cell & Regenerative Medicine.
JUVENTAS THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Medical Medical Device Therapeutics
Founded:
2007-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.juventasinc.com
Total Employee:
11+
Status:
Active
Contact:
(216)273-4000
Email Addresses:
[email protected]
Total Funding:
48.72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Content Delivery Network Apache Google Maps JsDelivr GoDaddy DNS GStatic Google Static Content Google Maps API
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Synnovation Therapeutics
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
POSCO Venture Capital
POSCO Venture Capital investment in Series B - Juventas Therapeutics
Green Cross
Green Cross investment in Series B - Juventas Therapeutics
Early Stage Partners
Early Stage Partners investment in Series B - Juventas Therapeutics
North Coast Ventures
North Coast Ventures investment in Series B - Juventas Therapeutics
Triathlon Medical Venture Partners
Triathlon Medical Venture Partners investment in Series B - Juventas Therapeutics
Reservoir Venture Partners
Reservoir Venture Partners investment in Series B - Juventas Therapeutics
Venture Investors
Venture Investors investment in Series B - Juventas Therapeutics
New Science Ventures
New Science Ventures investment in Series B - Juventas Therapeutics
Takeda Ventures
Takeda Ventures investment in Series B - Juventas Therapeutics
Fletcher Spaght, Inc.
Fletcher Spaght, Inc. investment in Series B - Juventas Therapeutics
Official Site Inspections
http://www.juventasinc.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Juventas Therapeutics"
Juventas Therapeutics - Crunchbase Company Profile …
Organization. Juventas Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Juventas Therapeutics is a clinical-stage biotechnology company developing …See details»
Juventas Therapeutics - Overview, News & Similar companies
Juventas Therapeutics contact info: Phone number: (216) 273-4000 Website: www.juventasinc.com What does Juventas Therapeutics do? Juventas Therapeutics, …See details»
Juventas Therapeutics, Inc. Overview | SignalHire Company Profile
Organization Website: juventasinc.com : Social Links: Phone Number: 216-273-4000: Juventas Therapeutic... industries Biotech, Biotechnology: Headquarters Location: 3615 Superior …See details»
Juventas - Home
Founded in June 2018, Juventas Cell Therapy Ltd. is a biopharmaceutical company focusing on the R&D and commercialization of innovative drugs such as immune cell therapy, which has in …See details»
Juventas Therapeutics, Inc. Company Profile | Cleveland, OH ...
Find company research, competitor information, contact details & financial data for Juventas Therapeutics, Inc. of Cleveland, OH. Get the latest business insights from Dun & Bradstreet.See details»
Juventas Therapeutics Company Profile | Management and
[email protected]: Juventas Therapeutics Top Competitors. Company Employees Revenue Top technologies; TissueGene Inc. 31: $7.5 M: TotipotentRX Corp. 20: $4.2 M: Actinogen …See details»
Juventas Therapeutics Inc - Company Profile and News
Company profile page for Juventas Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Juventas Therapeutics - Craft
Juventas Therapeutics is a biotechnology company developing non-viral gene therapies. It offers JVS-100, a non-viral gene therapy that expresses stromal cell-derived factor-1, or SDF-1, a …See details»
Juventas Therapeutics - PitchBook
Juventas Therapeutics General Information Description. Developer of regenerative therapies intended to treat cardiovascular diseases and ischemic disorders. The company's therapies …See details»
Juventas Therapeutics - Contacts, Employees, Board Members, …
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.See details»
Juventas Company Profile - Office Locations, Competitors ... - Craft
Juventas has 1 employees at their 1 location and $170.3 m in total funding,. See insights on Juventas including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Juventas - Contacts, Employees, Board Members, Advisors & Alumni
Juventas is a provider and developer of innovative immune cell therapeutic drugs.See details»
Juventas Therapeutics, Inc. | Insights
Jun 18, 2019 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Juventas Therapeutics Adds $13.5 Million In New Financing And …
CLEVELAND, May 12, 2015 -- Juventas Therapeutics, Inc., a clinical-stage biotechnology company focused on developing non-viral gene therapies to treat advanced cardiovascular …See details»
Juventas - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Juventas | Your Personalized Path to Optimal Health
Welcome to Juventas, your premier destination for integrated and forward-thinking healthcare solutions. Our membership opens the door to an array of personalized services, including total …See details»
Juventas - Overview, News & Similar companies | ZoomInfo.com
Dec 3, 2019 Who is Juventas. Juventas Cell Therapy Ltd. is a China-based domestic biopharmaceutical company established in 2018 focused on clinical translation and …See details»
Juventas - Crunchbase Company Profile & Funding
Juventas is a provider and developer of innovative immune cell therapeutic drugs. The company's first investigational new drug application for the cell therapeutic product CNCT19 has been …See details»
Juventas Cell Therapy closes a $63M funding round as it eyes a big …
Oct 25, 2021 Juventas has grabbed a $63 million series C to advance its CASI Pharmaceuticals-partnered drug CNCT19. The new swag will be used toward an NDA for the cell therapy as it …See details»
Juventas - Crunchbase Company Profile & Funding
Juventas distributes pharmaceutical products.Juventas and its affiliates market products used primarily by medical specialists in both surgical and non-surgical therapy and regenerative …See details»